Calendar Alnylam Pharmaceuticals, Inc.

Equities

ALNY

US02043Q1076

Market Closed - Nasdaq 04:30:00 2024-03-18 pm EDT 5-day change 1st Jan Change
147.4 USD -1.25% Intraday chart for Alnylam Pharmaceuticals, Inc. -1.13% -22.99%

Chart calendar Alnylam Pharmaceuticals, Inc.

cbb0b9130611d6957c6c11d54e03bbd5._-bY_YuTxRTu5qYprK9r_K3-aBRYNmsX3jzRVNrLtZk.kpSLtdj36HK3ivVLyd4IiMnIBmYdRzFj5guUEr-z-uqNkuuc6NKzJ56EzQ~67b43a104e236690a56ae781191a12e3

Upcoming events on Alnylam Pharmaceuticals, Inc.

2024-03-20 10:00 am Stifel CNS Day
2024-03-25 01:00 pm Canaccord Genuity Genetic Medicine for Generalists Conference
2024-04-24 Q1 2024 Earnings Release (Projected)
2024-07-30 Q2 2024 Earnings Release (Projected)
2024-10-23 Q3 2024 Earnings Release (Projected)
2025-02-05 Q4 2024 Earnings Release (Projected)

Past events on Alnylam Pharmaceuticals, Inc.

2024-03-12 10:15 am Barclays Global Healthcare Conference
2024-03-05 09:10 am TD Cowen Health Care Conference
2024-02-15 08:30 am Q4 2023 Earnings Call
2024-02-15 08:00 am Q4 2023 Earnings Release
2024-01-08 12:45 pm JPMorgan Healthcare Conference
2023-12-13 08:30 am R&D Day
2023-11-29 09:30 am Piper Sandler Healthcare Conference
2023-11-14 09:45 am Stifel Healthcare Conference
2023-11-14 05:00 am Jefferies London Healthcare Conference
2023-11-02 08:30 am Q3 2023 Earnings Call
2023-11-02 08:00 am Q3 2023 Earnings Release
2023-10-24 Clinical Trials on Alzheimers Disease Conference
2023-10-09 08:30 am ONPATTRO FDA Approval Call
2023-10-08 08:24 am Heart Failure Society of America Scientific Meeting - Poster 030
2023-10-07 05:21 pm Heart Failure Society of America Scientific Meeting - Poster 021
2023-10-06 07:00 pm Heart Failure Society of America Scientific Meeting - Poster 087
2023-08-10 10:30 am Canaccord Genuity Growth Conference
2023-08-03 08:30 am Q2 2023 Earnings Call
2023-08-03 08:00 am Q2 2023 Earnings Release
2023-07-24 08:00 am Alnylam Pharmaceuticals, Inc and Roche Holding AG Collaboration Agreement Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
220
221
-0.43%
493
476
3.49%
844
823
2.64%
1 037
1 013
2.41%
1 828
1 827
0.1%

1 837

EBITDA
Million USD
Released
Forecast
Spread
-885
-857
-3.28%
-794
-773
-2.74%
-661
-608
-8.65%
-741
-646
-14.71%
0,00
-250
-

-362

EBIT
Million USD
Released
Forecast
Spread
-939
-893
-5.24%
-828
-833
0.51%
-709
-665
-6.58%
-785
-813
3.38%
-282
-275
-2.6%

-426

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-885
-853
-3.84%
-856
-826
-3.59%
-852
-750
-13.68%
-1 127
-1 138
1%
-434
-437
0.72%

-511

Net income
Million USD
Released
Forecast
Spread
-886
-860
-3.08%
-858
-832
-3.22%
-853
-758
-12.46%
-1 131
-1 156
2.16%
-440
-441
0.12%

-524

EPS
USD
Released
Forecast
Spread
-8,11
-7,93
-2.21%
-7,46
-7,18
-3.86%
-7,20
-6,42
-12.12%
-9,30
-9,42
1.32%
-3,52
-3,53
0.29%

-4,17

Announcement Date06/02/2011/02/2110/02/2223/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
259
234
10.66%
213
243
-12.17%
225
256
-12.2%
264
292
-9.38%
335
312
7.23%
319
313
2.16%
319
351
-9.08%
751
395
90.22%
440
442
-0.58%

425


461


464


487


505

EBITDA
Million USD
Released
Forecast
Spread
-183
-138
-32.84%
-137
-200
31.43%
-182
-206
11.98%
-247
-118
-110.59%
-174
-185
5.58%
-136
-204
33.36%
-217
-135
-60.01%
227
-134
269.42%

-143


-123


-110


-75,4


-52,6




EBIT
Million USD
Released
Forecast
Spread
-195
-158
-23.33%
-147
-211
30.37%
-192
-173
-11.02%
-258
-195
-32.42%
-189
-221
14.57%
-150
-180
16.95%
-230
-136
-69.1%
214
-165
229.79%
-116
-114
-2.24%

-117


-97,7


-113


-106


-111

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-260
-181
-43.44%
-239
-234
-2.18%
-275
-206
-33.41%
-406
-224
-81.14%
-207
-266
22.17%
-172
-237
27.24%
-274
-162
-68.79%
151
-206
173.12%
-138
-149
7.5%

-133


-114


-133


-124


-128

Net income
Million USD
Released
Forecast
Spread
-258
-181
-42.6%
-240
-235
-2.25%
-277
-205
-35.27%
-406
-221
-84.03%
-207
-234
11.5%
-174
-217
19.87%
-276
-168
-64.42%
148
-184
180.46%
-138
-157
12.18%

-145


-127


-139


-121


-129

EPS
USD
Released
Forecast
Spread
-2,16
-1,54
-40.21%
-2,00
-1,90
-5.45%
-2,29
-1,64
-39.55%
-3,32
-1,81
-83.85%
-1,68
-1,93
12.92%
-1,40
-1,73
19.14%
-2,21
-1,42
-56.08%
1,18
-1,47
180.25%
-1,10
-1,25
11.8%

-1,16


-1,04


-1,10


-0,97


-0,99

Announcement Date10/02/2228/04/2228/07/2227/10/2223/02/2304/05/2303/08/2302/11/2315/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise